Monthly Archives: August 2021

Everyone is ready to laugh again, and 23 comedians are on their way to Columbus to help – The Columbus Dispatch

Posted: August 28, 2021 at 12:47 pm

Michael Grossberg| Special to The Columbus Dispatch

Jim Gaffigan, Nikki Glaser, Chelsea Handler, D.L. Hughley, Kevin James, Leanne Morgan, Brian Regan, Ron White and Steven Wright are just of a few of the many stand-up comedians and comedy acts visiting Columbus next season eager to resume touring after the worst of the pandemic is, hopefully, behind us.

Along with locally produced central Ohio comedy shows such as Shadowbox Live (with a new edition of Holiday Hoopla) andMadLabTheatre (producing its first Love and Laughter Festival as a showcase for five smaller troupes), such comedy shows aim to satisfy audiences eager to laugh again after a long lockdown of live comedy.

When: 7 p.m. Sept.10

Where: Palace Theatre, 34 W. Broad St.

What: The Chicago-born comedian is known for his distinctive physical style; roles in the films Green Book and The Irishman; TV comedy specials forNetflix, Showtime and Comedy Central; and for being honored by Billboard as their inaugural Comedian of the Year.

Admission: $63.25 to $153.13

Information:CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 8 p.m. Sept. 13

Where: Riffe Centers Davidson Theatre, 77 S. High St.

What: The larger-than-life drag queen and outrageous comic, a self-professed clown in a gown otherwise known as Ray Haylock, became well-known from winning the sixth season of "RuPauls DragRace" withher snarky frankness, timing and politically incorrect humor.

Admission: $41.50 to $227

Information:CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 p.m. Sept.16

Where: Palace Theatre, 34 W. Broad St.

What: The comedian, who has appeared on The View, Dr. Phil and Sirius XM comedy channels, is known for her southern charm and storytelling about her life as a mother of three with a husband.

Admission: $35 on rear main floor and rear balcony, but mostly sold out

Information: CBUSArtsTicket Center, 614-469-0939,www.cbusarts.com

When: 8 p.m. Sept. 18

Where: Palace Theatre, 34 W. Broad St.

What: The bestselling comedian, whos had four comedy specials on Comedy Central and Netflix and reached No. 1 on Billboard charts for his comedy album LiveFromSeattle, is known for comedy about his family and son, and the intricacies of Filipino traditions.

Admission: $48 to $188

Information:CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7:30 p.m. Sept. 30

Where: Riffe Centers Davidson Theatre, 77 S. High St.

What: The Columbus Association for the Performing Arts will present the two Canadian moms, bestselling authors and Facebook/Instagram favorites whose touring comedy show (including male dancers) focuses on moms and dismantles unrealistic media portrayals of motherhood comedian moms.

Admission: $28.25 to $107

Information:CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 8 p.m. Oct. 9

Where: Riffe Centers Davidson Theatre, 77 S. High St.

What: A nurse before he became a comedian and internet sensation, Orlando native Blake Lynch is known for his humorous videos on the lives of nurses and patients, and for leading a successful campaign through his Bannned4Life organization to raise awareness and repeal an outdated FDA ban on gay men donating blood.

Admission: $34 to $109

Information:CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 p.m. Oct.22

Where: Lincoln Theatre, 769 E. Long St.

What: The Columbus Association for the Performing Arts will present the comedian-actor/radio host, who starred in the Netflix comedy special Tom Papa: Youre Doing Great! and wrote the book Your Dad Stole My Rake: And Other Family Dilemmas.

Admission: $29.30 to $58.70

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 8 p.m. Oct. 22

Where: Palace Theatre, 34 W. Broad St.

What: The Atlanta-born comedian-podcaster-actress, billed as your favorite high-functioning hot mess, became famous for her Instagram page and self-deprecating style.

Admission: $36.50 to $166.50

Information: CBUSArtsTicket Center, 614-469-0939,www.cbusarts.com

When: 7 p.m. Oct. 29

Where: Palace Theatre, 34 W. Broad St.

What: The comedian, whos performed two Netflix specials The Tennessee Kid and The Greatest Average American, has appeared on late-night TV shows with Conan O'Brien and Jimmy Fallon, hosts a weekly Nateland podcast and has performed more than five times for U.S. troops.

Admission: $39.75 to $159.75

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 p.m. Nov. 7

Where: Palace Theatre, 34 W. Broad St.

What: The comedian-actor starred for nine seasons in the CBS series The King of Queens, co-starred with Adam Sandler in theGrownUps filmsandI Now Pronounce You Chuck and Larry; and produced, co-wrote and starred in the Paul Blart: MallCop filmcomedies.

Admission: $45 to $75

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 p.m. Nov. 12

Where: Southern Theatre, 21 E. Main St.

What: The Columbus Association for the Performing Arts will present the comedian, a Cincinnati native who likes to talk about sex and dating, hosts podcasts, and produces and hosts MTV and Comedy Central shows.

Admission: $38.50

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 and 9:30 p.m. Nov. 13

Where: Riffe Center, Davidson Theatre, 77 S. High St.

What: The comedian-actor-podcaster and TV personality hosts the This Past Weekend podcast and co-hosts the King and the Sting podcast with comedian Brendan Schaub.

Admission: $45.60, but mostly sold out

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 p.m. Nov. 13

Where: Palace Theatre, 34 W. Broad St.

What: The comedian, who had a seven-year run as host of E!s late-night show Chelsea Lately, has written six bestselling books (five that reached No. 1 on the New York Times bestseller list), including 2019s Life Will Be the Death of Me.

Admission: $49.50 to $126 to $219.50

Information: CBUSArtsTicket Center, 614-469-0939,www.cbusarts.com

When: 7 p.m. Nov. 14

Where: Nationwide Arena, 200 W. Nationwide Blvd.

What: The comedian-actor-writer-producer, nominated six times for Grammy Awards and a multi-platinum-selling recording artist, has written two bestselling books.

Admission: $39.75 to $79.75

Information: 614-246-2000,www.nationwidearena.com

When: 7 and 9:30 p.m. Nov. 18

Where: Riffe Centers Davidson Theatre, 77 S. High St.

What: The writer-actor-comedian-musician isisknown for viral videos and his sketches about the quirks of particular groups (Millennial Girlfriend School, Moms and Middle Schoolers During Flu Season Be Like).

Admission: $35 to $99

Information: CBUSArtsTicket Center, 614-469-0939,www.cbusarts.com

When: Nov. 18 through Dec. 23

Where: 503 S. Front St.

What: Shadowbox Live presents a new edition of its annual holiday production, the troupes most popular company-created sketch-comedy and music show, offering songs and original sketches celebrating the season and poking fun at holiday and family stresses.

Admission: $80 to $130 for tables of two;or $160 to $260 for tables of four

Information: 614-416-7625,www.shadowboxlive.org

When: 8 p.m. Nov. 19

Where: Palace Theatre, 34 W. Broad St.

What: The scotch-drinking, cigar-smoking comedian, rescheduled from 2020 because of the pandemic, shares stories from real life fromgrowing up in a small Texas town to his career-launching experiences from theBlue CollarComedy Tour.

Admission: $50.25

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: Nov. 19-21

Where: Funny Bone Comedy Club, Easton Town Center

What: The comedian, whose act is suggested for mature audiences, produced and starred in a namesake ABC/UPN TV sitcom, hosts an afternoon nationally syndicated radio show and wrote the book How Not to Get Shot, And Other Advice from White People.

Admission: to be announced

Information: 614-471-5653,www.columbus.funnybone.com

When: 7 p.m. Nov. 20

Where: Palace Theatre, 34 W. Broad St.

What: The California-native comedian, described by Variety in 2019 as one of the Top 10 Comics to Watch, has appeared on Comedy Central, late-night TV talk shows, and had her first Netflix show (Quarter-Life Crisis) in 2020.

Admission: $29.75 to $139.75

Information: CBUSArtsTicket Center,614-469-0939,www.cbusarts.com

When: 7 p.m. Dec. 9

Where: Riffe Centers Davidson Theatre, 77 S. High St.

See the rest here:
Everyone is ready to laugh again, and 23 comedians are on their way to Columbus to help - The Columbus Dispatch

Posted in Politically Incorrect | Comments Off on Everyone is ready to laugh again, and 23 comedians are on their way to Columbus to help – The Columbus Dispatch

Equivocation as a Tactic in the Evolution Debate – Discovery Institute

Posted: at 12:47 pm

Photo: Eugenie Scott, by Sgerbic, CC BY-SA 3.0 , via Wikimedia Commons.

Writing at Evolution News, Casey Luskin points out that a survey, reporting that a majority of Americans now accept evolution, didnt address the real issue. That is because evolution is not adequately defined. A co-author of the study, Eugenie Scott of the National Center for Science Education, has been doing this for a long time.

See the following from Chapter One of my 2006 book, The Politically Incorrect Guide to Darwinism and Intelligent Design:

The many meanings of evolution are frequently exploited by Darwinists to distract their critics.Eugenie Scott recommends: Define evolution as an issue of the history of the planet: as the way we try to understand change through time. The present is different from the past. Evolution happened, there is no debate within science as to whether it happened, and so on I have used this approach at the college level.1

Of course, no college student indeed, no grade-school dropout doubts that the present is different from the past.Once Scott gets them nodding in agreement, she gradually introduces them to The Big Idea that all species including monkeys and humans are related through descent from a common ancestor.Darwin called this descent with modification, and it is still the best definition of evolution we can use.2

This tactic is called equivocation changing the meaning of a term in the middle of an argument.

Note that even Scotts best definition omits the real sticking point, namely that Darwinian descent with modification is (according to Darwin) unguided.

How many Americans accept Darwins belief that human beings are the result of an unguided, purposeless process? The survey doesnt come close to telling us.

Read more from the original source:
Equivocation as a Tactic in the Evolution Debate - Discovery Institute

Posted in Politically Incorrect | Comments Off on Equivocation as a Tactic in the Evolution Debate – Discovery Institute

Oliver Bucher complains: ‘The situation is getting worse every day’ – Socialpost

Posted: at 12:47 pm

Oliver Bucher found clear words on the topic of political correctness. BUILD: IMAGOO IMAGES / IMAGE OF THE FUTURE

Oliver Bucher Always available for controversial ads. So he recently took over Instagram For example, Kathy Hummels was targeted when she announced that she would be gender-neutral in the future language Application. In the talk of the image08:15It was now so explicitly about political correctness that the comedian found clear words. In addition, a completely different topic was taken up: the 43-year-olds retirement pension.

What is comedy allowed to do nowadays? asks Bucher on the set, which also featured Sofia Tomala and Bild head policy, Jan Schaefer. for him Opinion There should be no limits to humor. It should be possible to make fun of politically incorrect things, he demanded. In his view, this is (no longer) easily possible at the moment at least you risk a storm of bullshit in social networks. Pocher complained:

A father of five also complained of a movement towards the abolition of culture. They also mentioned that he now has scissors in his head that always prevents him from saying things in public. It was a bitter epilogue things are getting worse every day, while the black humor is liberating. Anyway, making humor naturally became more difficult.

But theres more bad news for him, too, as the comedian recently wrestled with his current statutory pension entitlement. Result: Currently I get 300 to 400 euros. As a reason, Bucher cites that not much is paid in the statutory retirement system, only some acting jobs require a deposit.

The pension system cannot be maintained at all everyone knows thatPocher then immediately summarizes and criticizes the fact that topics like this are completely neglected in the current election campaign.

(Atmosphere)

The semi-finals of Celebrity Big Brother were announced on Saturday 1st, and the remaining nominees have endured each other for nearly three weeks. However, the final episode was overshadowed by controversy, with fans on social media suspecting that the live game wasnt quite right.

The challenge was to make the helium balloon leash disappear in the mouth as quickly as possible. Turns out Melanie Mueller is an expert

Article link

Travel aficionado. Certified problem solver. Pop culture guru. Typical writer. Entrepreneur. Coffee trailblazer.

Excerpt from:
Oliver Bucher complains: 'The situation is getting worse every day' - Socialpost

Posted in Politically Incorrect | Comments Off on Oliver Bucher complains: ‘The situation is getting worse every day’ – Socialpost

America Must Now Crush the Taliban and ISIS-K and By Phyllis Chesler – Yonkers Tribune.

Posted: at 12:47 pm

Phyllis Chesler is an Emerita Professor of Psychology at City University of New York. She is a best-selling author, a legendary feminist leader, a retired psychotherapist and expert courtroom witness. She has lectured and organized political, legal, religious, and human rights campaigns in the United States, Canada, Europe, Israel, and the Far East. Dr. Chesler is a co-founder of the Association for Women in Psychology (1969), The National Womens Health Network (1974), and The International Committee for Women of the Wall (1989). She is a Shillman-Ginsburg Fellow at The Middle East Forum, and a fellow at the Institute for the Study of Global Antisemitism and Policy (ISGAP). Professor Chesler may be reached at her website http://www.phyllis-chesler.com

NEW YORK, NY August 26, 2021 I know. Strategy is everything. Without weighing all the consequences, without planning a long range game, we end up in Kabul as it is today, on 8/26/21. And yet: ISIS-K is also fighting with the Taliban. I say: Get em both. This cannot stand. They have just killed the bravest of our soldiers who were engaged in a humanitarian rescue mission.

Do not believe the Taliban promises about being a kinder, gentler organization. They have been terrorizing people all across the country and beating and whipping people as they tried to escape.

Its Bidens war now. He has shamed and dishonored our country in a breathtaking way. He brought it on himself, on our NATO allies, and on all the Afghans who came to believe in Western post-Enlightenment values. Biden shut the airports down and left military equipment behind before the very last soldier, the very last Afghan ally, dissident, gay, feminist were safelyvery safely out.

Biden (his character, his flaws, his stubbornness), his administration, and whoever is pulling their strings are to blame.

This cannot stand.

Books written by Author / Prof. Phyllis Chesler

# # #

The dramatic, riveting, and timely tale of how one womans harrowing ordeal in a harem in Afghanistan shaped her into a modern feminist leader and life-long defender of human rights. Eighteen years old and in love, Phyllis Chesler, a Jewish-American girl from Brooklyn, embarked on a passionate love affair with a glamorous foreign student, which led Chesler to her destiny and nearly to her death in Kabul and to a journey which has lasted for more than half a century. Upon arrival, Afghan authorities seized her American passport, and Chesler found herself trapped as the property of her husbands polygamous family, without an ally and without any rights. Despite her seclusion, her mother-in-laws campaign to convert her from Judaism to Islam, and her husbands wish to permanently tie her to the country through childbirth, she escaped. Yet these lovers, a Muslim and a Jew, have remained connected ever since.

Chesler draws upon personal diaries, correspondence, memories, and research in this vivid and eye-opening account of what she learned about central Asia and the nature of gender apartheid. Though she nearly died in Afghanistan, Phyllis nostalgically recreates this beautiful, ancient, and exotic culture and country, including its Buddhist and Jewish history. An American Bride in Kabul is the story of how a nave American girl learned to see the world through eastern as well as western eyes. She re-creates a time gone by, a place that is no more, and shares the way in which Chesler turned adversity into a passion for freedom and womens rights.

This is a psychological adventure story and constitutes another kind of travel literature. What Chesler learned about Afghan and Islamic culture will help us understand many of the global challenges of the 21st centuryincluding fundamentalist misogyny, religious intolerance, terrorism, the fate of progressives, and cultural misunderstandings.

# # #

Phyllis Chesler is the author of 18 books, including An American Bride in Kabul and A Politically Incorrect Feminist.She is also a 2013 recipient of the National Jewish Book Award, and a Ginsburg-Ingerman Fellow at the Middle East.

See the original post here:
America Must Now Crush the Taliban and ISIS-K and By Phyllis Chesler - Yonkers Tribune.

Posted in Politically Incorrect | Comments Off on America Must Now Crush the Taliban and ISIS-K and By Phyllis Chesler – Yonkers Tribune.

LETTER TO THE EDITOR: Don’t assume that humans cause climate change – The Central Virginian

Posted: at 12:47 pm

I applaud the efforts described by Sara Elder (July 29) and Peter Sugarman (Aug. 12) regarding the work by Louisa County High School students to learn about climate change. Involvement with major issues, at the age of these students, can only help us toward a better future.

It is unfortunate, however, that each of these letters adds to the confusion about the causes of climate change. Both bow to political correctness and in the process confuse weather with climate change. Yes, the carbon emissions by mankind contribute to global warming. And yes, we are experiencing unusual weather events, but not that unusual if we look back over the past 100 years. What is generally misunderstood is the relatively large component of climate change that is a result of natural causes. These natural phenomena include changes in the orbit of the earth around the sun, changes in the tilt of the earth in its orbit, precession (wobble) of the earth in its orbit, changes in the level of the suns radiation, changes in the amount of radiation reaching the earths atmosphere, etc.

Over the past 20,000 years we have been in a warming period. There had been a massive, thick ice sheet covering much of North America, and Northern Europe and Asia. Over this period there is evidence of intermediate temperature variations of plus or minus 4 to 5 degrees Celsius. These changes have all occurred without any contribution from the activities of mankind. This is happening whether or not we make substantial efforts to reduce man-made carbon emissions. We ought to do what we can to minimize carbon emissions at a reasonable cost, but what we achieve is unlikely to produce a measurable effect on the trajectory of temperature change in the environment.

Where we can make a meaningful difference, however, is in taking measures that help us adapt to the changes that are certain to occur. These include avoiding building in floodplains and on the ocean shore line. We need to manage our forests better, to eliminate the materials that can feed large fires. We can also look at measures that would block some of the suns radiation from reaching the surface of the earth. We can take measures to adapt to living in a warmer climate, realizing that more people today die due to cold temperatures rather than the heat.

I realize that this view is generally considered to be politically incorrect. The woke folks will tell you that the science of climate change is settled. The climate change we are experiencing is primarily caused by the actions of mankind, through the emission of greenhouse gases. You know this is so by listening to the political pundits discussing the results reported in the various United Nations IPCC (International Panel of Climate Change) reports that have been issued over the years. Fortunately, there have been a number of scientists who have taken the trouble to analyze the raw data behind the reports before it is filtered by editors through political lenses to suit the current correct narrative on this subject.

It is beyond the scope of a letter to the editor to present a full explanation of the current scientific views of climate change. I highly recommend, however, a book on this subject by Dr. Steven Koonin, a professor in the Department of Civil and Urban Engineering at New York University. Dr. Koonin was an advisor in the Obama Administration. Before that he spent 30 years teaching at Caltech, specializing in data analysis and generating mathematical models using this data. The title of the book (published in April 2021) is Unsettled, What Climate Science Tells Us, What it Doesnt, and Why It Matters. The publisher is BenBella Books, Dallas, Texas.

Originally posted here:
LETTER TO THE EDITOR: Don't assume that humans cause climate change - The Central Virginian

Posted in Politically Incorrect | Comments Off on LETTER TO THE EDITOR: Don’t assume that humans cause climate change – The Central Virginian

Uyghur Entrepreneur Confirmed to be Held in Internment Camp in Xinjiang – Radio Free Asia

Posted: at 12:47 pm

A leading Uyghur entrepreneur who returned from a visit to the United States in 2016 and vanished without a trace has been confirmed detained by authorities in an internment camp in the Xinjiang region of northwestern China, sources familiar with the case told RFA.

Mahmutjan Memetjan, 35, was picked up by authorities in 2017, the year authorities in the Xinjiang Uyghur Autonomous Region (XUAR) launched a vast network of internment camps that has incarcerated some 1.8 million Uyghurs and other Muslim minorities accused of harboring strong religious views and politically incorrect ideas, RFA has learned from a source in the region.

The real estate investor, also known as Mehetjan Alqut, had lived in in Yengisheher (in Chinese, Shule) county, in Kashgar (Kashi) prefecture, where he ran the Kashgar Alqut Property Company.

Chinese authorities have targeted and arrested numerous Uyghur businessmen, intellectuals, and cultural and religious figures in the XUAR for years as part of a campaign to monitor, control, and assimilate members of the minority group purportedly to prevent religious extremism and terrorist activities.

Mahmutjan and other entrepreneurs went on a group business trip to the U.S. on April 8-22, 2016, according to the source inside the XUAR. During the visit, his then-pregnant wife, Parida Ilgar, gave birth to the couples fourth daughter, who became a U.S. citizen and received a passport.

In May 2017, not quite a year after the delegation returned home, Yengisheher county police detained Mahmutjan and questioned him about his travels to the U.S., said the source, who declined to be named in order to speak freely.

A police officer in Yengisheher county told RFA that Mahmutjans case had been handled by Yu Tiantian, a Han Chinese police officer from the same work unit.

The police officer from a station near a 16-storey apartment and retail building called Alkut owned by Mahmutjan said he knew that the businessman had been taken into custody and detained four years ago, but did not know the reason for his arrest.

Since his detention and disappearance, Mahmutjan has been held in a reeducation or training center, Chinas euphemistic terms for the XUAR internment camps, said the officer, who did not provide his name.

He also said he was unaware of the situation of Mahmutjans wife and children, including their U.S.-born daughter.

Asked about the state of Mahmutjans businesses, the police officer said: Some are open, some are closed following the businessmans detention.

In addition to his holdings in Yengisheher, Mahmutjan also reportedly opened and operated an organic food market called Iztap in the Dawan neighborhood of the XUARs capital Urumqi (Wulumuqi), and a home interior company on the citys Yanan Road.

The organic food market and the home interior company may have been shut down by the authorities following Mahmutjans disappearance in 2017, said the first source.

Mahmutjans wife is currently living in Urumqi, where she has faced great difficulties since her husbands detention, the source said.

Reported by Shohret Hoshur for RFAs Uyghur Service. Translated by the Uyghur Service. Written in English by Roseanne Gerin.

Continue reading here:
Uyghur Entrepreneur Confirmed to be Held in Internment Camp in Xinjiang - Radio Free Asia

Posted in Politically Incorrect | Comments Off on Uyghur Entrepreneur Confirmed to be Held in Internment Camp in Xinjiang – Radio Free Asia

Eczema | Johns Hopkins Medicine

Posted: at 12:46 pm

What is atopic dermatitis?

Atopic dermatitis is a chronic skin disorder. It causes dry, itchy, scaly patches on the skin, often on the face and scalp in babies. Its most common in infants or very young children. Most will show signs of the condition in the first year of life. Symptoms may last until the teens or adulthood. It rarely starts in adulthood. Atopic dermatitis is not contagious.

Atopic dermatitis tends to run in families. This suggests a genetic link. Its also associated with asthma and allergies. These are immune hypersensitivity disorders.

Treatment for this condition is aimed at calming the skin inflammation, decreasing the itching, and preventing infections. Good skin care and medicine to control itching and infection are used.

Atopic dermatitis is often called eczema.

The exact cause of atopic dermatitis is not known. It runs in families, which suggests a genetic link. Its also linked to asthma and allergies. There is likely an alteration of the proteins in the skin that leads to atopic dermatitis.

Certain triggers can make atopic dermatitis worse. For example, stress, hot or cold temperature, dry conditions, certain fabrics, or detergents can cause a flare-up.

The area of the body affected by atopic dermatitis may change with age. In infants and young children, it usually affects the face, outside of the elbows, and on the knees. In older children and adults, it tends to be on the hands and feet, the arms, on the back of the knees, and the folds of the elbows.

Symptoms are slightly different for each person. Common symptoms include:

Too much rubbing and scratching can tear the skin and lead to infection.

The symptoms of atopic dermatitis may look like other skin conditions. Always talk with your healthcare provider for a diagnosis.

Your healthcare provider will ask about your health history and whether you have allergies or asthma. He or she will also ask about any family history of dermatitis, allergies, or asthma.

A healthcare provider can often diagnose atopic dermatitis by examining your skin. You may also have a patch test. This is used to find allergies by placing small amounts of allergens on the skin and watching for a response. A skin biopsy may also be done to rule out other causes of the rash.

Factors such as your age, overall health, and health history will help your healthcare provider find the best treatment for you.

There is no cure for atopic dermatitis. The goals of treatment are to reduce itching and inflammation of the skin, to keep the skin moist, and to prevent infection.

Your healthcare provider may also prescribe medicines in severe cases. The following are commonly used to treat atopic dermatitis:

Complications of atopic dermatitis include:

Because the cause of atopic dermatitis is not known, there is no known way to prevent it. But avoiding triggers may reduce flare-ups.

The following steps can help manage atopic dermatitis:

Tell your healthcare provider if your symptoms get worse or you have new symptoms.

Tips to help you get the most from a visit to your healthcare provider:

See more here:
Eczema | Johns Hopkins Medicine

Posted in Eczema | Comments Off on Eczema | Johns Hopkins Medicine

Eczema on eyelids: Causes, treatments, and more – Medical News Today

Posted: at 12:46 pm

Several types of dermatitis can produce eczema around the eyes and on the eyelids. This causes discoloration, itching, and swelling.

Atopic, contact, and seborrheic dermatitis can all cause eczema in the eye area.

They can be a result of exposure to allergens or irritants. Additionally, some people have a genetic hypersensitivity to the environment, making them more likely to react to irritants.

Doctors recommend treating this with a simple skin care routine that avoids scented products. They may also prescribe medication creams, like low-concentration hydrocortisone or topical calcineurin inhibitors.

Read more to learn about the types of dermatitis causing eczema around the eyes, their causes and triggers, and treatment options.

The terms eczema and dermatitis are often used interchangeably to describe dry, itchy skin. Technically, eczema refers to atopic dermatitis, a common form of dermatitis.

The inflammation associated with dermatitis can affect any area of skin, including the eyelids and skin surrounding the eyes.

It occurs more often in the eye area in individuals who already have it on other parts of the body. Some of the common types of dermatitis affecting the eye area include atopic, contact, and seborrheic.

Atopic dermatitis is the main type of eczema. Although it is primarily a skin condition, asthma and hay fever may also occur.

It is more common in adults than children, and can be caused by genetics, environmental factors, or both.

Atopic dermatitis may increase a persons risk of certain eye diseases. The eye rubbing associated with dry, itchy skin around the eyes can cause keratoconus, a corneal thinning disorder.

According to one research paper, the prevalence of eye complications in people with atopic dermatitis on or around the eyes ranges from 2550%.

Contact dermatitis causes the skin to become inflamed and irritated. This is usually in response to something that triggers an allergy. It is more common in people with sensitive skin.

Unlike atopic dermatitis, it is not accompanied by other allergic reactions and only affects the skin.

It makes the eyelids red or discolored and scaly and can cause them to sting and burn. The condition ranges from mild to severe.

When contact dermatitis occurs on or around the eyes, it may affect the upper lid, lower lid, or both. If the condition persists, it can cause the eyelids to thicken.

Seborrhoeic dermatitis affects the face, ears, eyebrows, eyes, and scalp. It is often swollen and greasy with a white or yellowish crust.

When it affects the eye area, it often appears only on the margins of the eyelids, which are the edges of the eyes.

This form of dermatitis is more common in adults and affects 310% of the population. Although serious complications are rare, it does increase a persons risk of developing a bacterial infection on the eyelids.

About 2540% of people with atopic dermatitis have severe inflammation of the conjunctiva, which is the thin membrane on the inside of the eyelid.

In contact dermatitis, the eyelids are red or discolored, scaly, and possibly swollen.

Seborrheic dermatitis of the eye usually affects only the eyelid margins.

When dermatitis and/or eczema occurs in the eye area, it can cause various symptoms. These include:

The different forms of dermatitis have different causes and triggers:

Atopic dermatitis is caused by a genetic hypersensitivity to the environment.

Triggers of flare-ups may include:

Exposure to allergens or irritants causes contact dermatitis. This may be a result of direct, indirect, or airborne contact.

Direct contact triggers may include exposure to the following products:

Indirect contact refers to contact through an individuals own hands. When this happens, a person may touch their eyes after touching a triggering item. These can include:

Airborne irritants may also trigger contact dermatitis. Examples of irritants include:

Researchers believe seborrheic dermatitis is an inflammatory reaction to excess Malassezia yeast. This yeast normally lives on the skins surface. However, when there is too much of it, the immune system overreacts, resulting in skin problems.

Triggers of seborrheic dermatitis may include:

When diagnosing eczema around the eyes, doctors examine a persons skin. They will also ask about a persons symptoms and medical history.

If they suspect a person has atopic dermatitis, they may decide to do a skin biopsy. This involves removing a small skin sample and sending it to a lab for testing. A doctor might also conduct a skin culture to see if the issue is bacterial or fungal.

A doctor suspecting contact dermatitis will conduct skin tests to determine if a person has allergies. They may also ask people about their occupations and hobbies to identify triggers.

Treatment will vary depending on the type of dermatitis a person has. For instance, a person with contact dermatitis may be told to identify and remove triggers from their daily routine.

According to the National Eczema Society, treatment usually involves skin care practices, mild topical steroid medications, and topical calcineurin inhibitors.

Experts recommend a simple skin care routine free of fragrances and irritants.

This includes:

A person applies topical creams and ointments directly to the skin.

Doctors generally advise using low concentration steroid ointments on the eyes. This is because the eyelid skin is very thin and delicate.

Some topical treatments are available over the counter, but others require a prescription.

A doctor may prescribe a moderate potency steroid for a severe eczema flare-up. However, they would only prescribe this for a short period of time, such as 5 days.

Topical calcineurin inhibitors (TCIs) are not a steroid, but they do help treat eyelid eczema. They require a prescription. Commonly prescribed TCIs include tacrolimus (Protopic) and pimecrolimus (Elidel).

Because they are not a steroid, they do not thin the eyelid skin. However, they do increase the skins sensitivity to sunlight, so people should take precautions when using them.

Various complications may accompany dermatitis around the eyes. They include:

Also called conjunctivitis, this is the inflammation of the thin tissue covering the white parts of the eyes.

Symptoms include:

Keratitis is the medical term for an inflamed cornea.

Symptoms include:

Keratoconus is the term for changes in the shape of the cornea, the transparent covering of the iris and pupil. The cornea is normally round, but rubbing the eye can cause the cornea to bulge and become cone-shaped.

Symptoms and signs include:

Early diagnosis and treatment of keratoconus can minimize the potential vision loss.

Cataracts make the eyes lens progressively more opaque, resulting in blurred vision. In people with atopic dermatitis, cataracts usually occur in both eyes at the same time.

Factors like eye rubbing and the severity of any lesions determine how quickly cataracts will develop.

Retinal detachment is a serious complication of dermatitis around the eyes.

The retina is a thin layer of tissue at the back of the eye. When it detaches, it pulls away from the blood vessels that support it.

This can lead to permanent vision loss.

Several types of dermatitis may cause eczema in the eye area. Common types include focal, contact, and seborrheic dermatitis.

Treatment may include the application of low concentrations of hydrocortisone ointment, which may be available over the counter or require a prescription. Doctors may also prescribe topical calcineurin inhibitors.

Getting an early diagnosis and treatment protects the eyes and prevents vision loss.

Continue reading here:
Eczema on eyelids: Causes, treatments, and more - Medical News Today

Posted in Eczema | Comments Off on Eczema on eyelids: Causes, treatments, and more – Medical News Today

Eczema Gummies Are the Latest Skincare SupplementHere’s the 411 – Mane Addicts

Posted: at 12:46 pm

There;sWhether seasonally or year-round, severely or minimally, many people suffer from eczema. According to the National Eczema Organization, 31.6 million people in the U.S. have the rash-like skin condition in some form. And if youre one of those people, you know it can affect the scalp, too. Itchiness, burning and flakiness can plague the head if not given proper care.

Thats where Embodys SVP Alexis Starling comes to the rescue. While she renamed her latest production of supplements The S.O.S. Gummy (because theyre beneficial for all skin typesand ages!), they were initially geared towards consumers with eczema. Hence, their original name, The Eczema Gummy.

Whether youre on the hunt for eczema gummies or simply universally useful supplements packed with nutrients, youll want to read about this brand new launch, straight from Chung herself!

When we were getting ready to launch the Retinol Gummy in June 2020, the stress of launching a brand caught up to our teams skin, Starling tells Mane Addicts. The irritation and itchiness got so bad for me that I couldnt hold a pen anymore. We started researching holistic methods for supporting itch-free skin. In research, it was realized that I was likely vitamin D deficient and in need of some extra skin barrier love. We hurried off to Sprouts to buy vitamin D, MSM, and EPO supplements just to see what would happen. Within a few weeks, skin looked better and felt healthier with less itch and more smoothness. And that was the beginning of the S.O.S. Gummy!

The scalp is an often overlooked part of our skin, Starling explains. We often miss it when applying sunscreen, we pile hair styling products on it and we definitely dont give it as much skincare love as our faces. But the scalp can also experience irritation, dryness, and itchiness. A whole body approach like the S.O.S. Gummy is a great way to give your scalp some love without adding heavy serums or expensive treatments to your routine. What we love about gummy skincare is it works everywhere theres skin!

If you have an itchy or dry scalp, we recommend avoiding common irritants such as sodium laureth sulfate and heavy fragrances, Starling advises. We also encourage you to wash your hair less often and wash your pillowcases more often. Try a gentle scalp massage to get blood flowing to that area which can help reduce itching and regulate oil production.

Go here to read the rest:
Eczema Gummies Are the Latest Skincare SupplementHere's the 411 - Mane Addicts

Posted in Eczema | Comments Off on Eczema Gummies Are the Latest Skincare SupplementHere’s the 411 – Mane Addicts

This Potential Indication Could Mean Profit for Eli Lilly Investors – Motley Fool

Posted: at 12:46 pm

In mid-August, pharma stock Eli Lilly(NYSE:LLY) updated investors on phase 3 results of lebrikizumab, its potential treatment for patients with a chronic skin disease known as moderate to severe atopic dermatitis (or eczema). Let's delve into why those results look hopeful -- and how this could all translate into profit for Eli Lilly and its investors.

Image source: Getty Images.

First, a few words about eczema. The Asthma and Allergy Foundation of America (AAFA) describes it as a "chronic, inflammatory skin disease which results in widespread rashes and patches of itchy skin."

The AAFA estimates that approximately 16.5 million or 7.3% of adults in the U.S. are affected by the disease. The condition often leads to emotional burden as well as pain, physical discomfort, and sleep disturbances for patients, especially for those with moderate to severe cases.

Considering that moderate to severe eczema accounts for 40% of all atopic dermatitis cases in the U.S. (and possibly around the world), the potential market for lebrikizumab if approved by regulators, is massive. There remains a need for additional therapies.

Research firm Market Data Forecast expects that the global atopic dermatitis market will compound at an annual growth rate of 13.1% from $11.8 billion in 2021 to $21.8 billion in revenue by 2026.

How can we know if a medication will help? Researchers use a measure known as the Eczema Area and Severity Index (EASI), which assesses the extent (by area and severity) of atopic dermatitis. The greater the reduction in the EASI from a patient's pre-treatment baseline, the more effective a drug is in treating eczema.

Lebrikizumab's ongoing phase 3 trials consist of approximately 400 patients, age 12 and older, with moderate to severe eczema. The patients were randomly assigned to receive either a placebo or lebrikizumab for 16 weeks followed by a 36-week maintenance period. During that period, patients who had a good response to lebrikizumab (an EASI of 75 or greater) are randomly reassigned to one of three groups to further demonstrate its efficacy. Group A patients receive 250 milligrams of lebrikizumab every two weeks, group B receives 250 milligrams of lebrikizumab every four weeks, and group C is given a placebo every two weeks.

Though the phase 3 trials are ongoing and specific data won't be presented until next year when the trials conclude, Eli Lilly noted that lebrikizumab helped over half of its patients achieve at least a 75% improvement in the Eczema Area and Severity Index (EASI 75) at week 16 as a monotherapy (the only therapy). This suggests that lebrikizumab may be as effective in this way as Dupixent, made by Sanofi (NASDAQ:SNY) and Regeneron (NASDAQ:REGN). By comparison, Dupixent as a monotherapy helped 51% and 44% of patients achieve at least EASI 75 at week 16 in two clinical trials.

With over half of patients who receive lebrikizumab reporting at least EASI 75 (or at least 75% clearer skin), there was also far less itching and disruptions to sleep.Even better news for those suffering from moderate to severe atopic dermatitis is that no new safety risks were reported in the phase 3 trial, which means the drug is as safe as previously thought.

A big positive is that the trial reported only 1.4% of patients receiving lebrikizumab discontinued treatment due to adverse events, which is below the placebo group of 1.7%.

The key takeaways from the phase 3 trials of lebrikizumab were that it was almost as effective as the leader, Dupixent, in treating moderate to severe atopic dermatitis while being well tolerated by patients.

Lebrikizumab looks to be a great backup plan for Eli Lilly. That's because of safety concerns surrounding a drug class known as Janus kinase (or JAK) inhibitors. This is the drug class of the other atopic dermatitis hopeful that Eli Lilly owns, Olumiant.

Following Pfizer's (NYSE:PFE) post-marketing study of the JAK inhibitor Xeljanz (used to treat various forms of arthritis and ulcerative colitis), major heart side effects and cancers were reported. This led the Food and Drug Administration (FDA) to stop decisions on a number of JAK inhibitors until the safety of the class has been fully examined.

As potential FDA approvals for JAK inhibitors to treat atopic dermatitis are stalled -- among them, AbbVie's (NYSE:ABBV) Rinvoq, Eli Lilly's Olumiant, and Pfizer's abrocitinib -- lebrikizumab could end up being approved before those three candidates.

This is because there are no major safety concerns associated with lebrikizumab, which is an interleukin-13 (or IL-13) inhibitor. IL-13 is a protein that is often overexpressed in individuals with eczema. This results in an overactive immune system, which is what may bring on atopic dermatitis. By lowering the body's inflammatory response to IL-13 proteins, lebrikizumab has proven effective in treating atopic dermatitis to date in trials. This could help establish Eli Lilly's potential treatmentas second to only Dupixent in the atopic dermatitis market, especially if the FDA ultimately rejects JAK inhibitors for this indication.

Considering that 40% of eczema cases globally are moderate to severe and conservatively assuming a 6% market share, this indication for lebrikizumab could bring in over $500 million annually by 2026. While it may prove only to be the second- or third-most effective treatment, the safety profile could lead patients to discontinue other drugs to try lebrikizumab.

This forecast also reflects that Almirall, a Spanish pharmaceutical company, is licensed to develop and commercialize lebrikizumab in Europe for dermatology indications there, including atopic dermatitis.

At about 2% of Eli Lilly's forecast of $26.8 billion to $27.4 billion in revenue for this year, lebrikizumab could make meaningful contributions to Eli Lilly in the near future if approved.

Aside from its ambitions in the atopic dermatitis market, Eli Lilly has a number of growing drugs that should allow it to deliver high-single-digit to low-double-digit annual dividend growth for the foreseeable future.

Type 2 diabetes drug Trulicity's first-half 2021 revenue soared 22% -- from $2.46 billion in 2020 to $2.99 billion in 2021 -- and this should continue in the years ahead. Market research firm Research and Markets expects the type 2 diabetes market to nearly double from $48 billion in 2019 to $92 billion by 2029.

Plaque psoriasis and psoriatic arthritis drug Taltz saw its first-half 2021 revenue advance 16% -- from $839 million in 2020 to $972 million in 2021 -- suggesting the drug still has plenty of growth left in the tank.

Eli Lilly isn't cheap at 33 times analysts' average earnings-per-share forecast for this year of $7.90, but this is somewhat made up by the fact that they expect Eli Lilly's strong drug portfolio to generate 14.8% annual earnings growth over the next five years.

Healthcare investors looking for a quality company with growth on the horizon should consider starting a small position in Eli Lilly and adding on any dips.

This article represents the opinion of the writer, who may disagree with the official recommendation position of a Motley Fool premium advisory service. Were motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Continued here:
This Potential Indication Could Mean Profit for Eli Lilly Investors - Motley Fool

Posted in Eczema | Comments Off on This Potential Indication Could Mean Profit for Eli Lilly Investors – Motley Fool